Hands free towel carrying system
A hands free towel carrying system for coupling a towel to a user to prevent loss, theft or contamination.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7744926 | Use of a biologically active blood serum for the treatment of stroke The present invention relates to the use of a pharmacologically active blood serum product producible by a method comprising electrostimulation of a non-human animal, withdrawal of blood from said animal, isolation of serum from said blood, and gamma irradiation of ... | 06/29/2010 |
| 7344714 | Production of motif-specific and context-independent antibodies using peptide libraries as antigens The present invention is related to a method for producing motif-specific, context-independent antibodies which are specific to at least one modified amino acid residue in the context of variable surrounding amino acid or peptide sequences. The method is particularl... | 03/18/2008 |
| 7097554 | Animal fetus blood procurement tables and methods A method for extracting blood from animal fetus includes securing a placenta of an animal against a substantially planar face, the first face being disposed at an angle in a range between about 45° to about 110° relative to the horizontal. The placenta is massaged... | 08/29/2006 |
| 7094378 | Method and apparatus for inactivation of biological contaminants using photosensitizers Methods and apparatuses for treating fluids to inactivate microorganisms which may be present therein, said fluid containing one or more components selected from the group consisting of protein, blood and blood constituents are provided. The methods comprise adjusti... | 08/22/2006 |
| 7060300 | Bear derived isolate and method A bear derived isolate found in denning black bears or black bears from which food has been withheld for at least two weeks when injected into another mammal produces reduced heart rate, reduced respiratory rate, reduced temperature, and a wakeful tranquility not un... | 06/13/2006 |
| 7052720 | Spheroid preparation A mixture or substance having a spheroid-forming activity is obtained by heat treating fetal calf serum at a temperature and for a period sufficient to impart spheroid-forming activity. Introduced into cell culture, the substance or mixture so obtained causes cells ... | 05/30/2006 |
| 6984493 | Method for examining the involvement of opioid peptides in prurtis A method for examining a disease includes measuring plural opioid peptides or opioid receptors in blood cell, body fluid, or tissue and calculating the ratio thereof. The method can be specifically applied to pruritic diseases. The invented method for examination ca... | 01/10/2006 |
| 6899813 | Method for the production of a blood component composition A system for the production of a blood component composition is provided. The system includes a centrifuge having a blood reservoir for receiving and separating a blood sample into multiple components; a dispenser disposed outside of the centrifuge having a first co... | 05/31/2005 |
| 6867193 | Amino acid-containing albumin preparation An albumin preparation that prevents onset of hepatic encephalopathy caused by conventional amino acid preparations and enhances an effect of improving the symptoms is provided. The albumin preparation containing amino acids is characterized in that a content of alb... | 03/15/2005 |
| 6855337 | Bear derived isolate and method A bear derived isolate found in denning black bears or black bears from which food has been withheld for at least two weeks when injected into another mammal produces reduced heart rate, reduced respiratory rate, reduced temperature, and a wakeful tranquility not un... | 02/15/2005 |
| 6830762 | Autologous fibrin sealant and method for making the same The present relates to an autologous bioadhesive sealant composition or fibrin glue prepared by a two-phase method, wherein all of the blood components for the bioadhesive sealant are derived from a patient to whom the bioadhesive sealant will be applied. A platelet... | 12/14/2004 |
| 6783775 | Serum-derived factor inducing cell differentiation and medical uses thereof The present invention relates to a biologically active serum-derived composition of matter (SDF), having a low molecular weight, being electrically charged at acidic pH and having absorption at 280 nm. The molecular weight of said SDF was determined by electron spra... | 08/31/2004 |
| 6770278 | Methods of making and using immunoglobulin (Ig) compositions The invention is directed to methods of using Ig compositions to prevent and/or treat humans, livestock and/or domesticated animals suffering from stress induced respiratory disorders. The Ig composition comprises a concentrated amount of one or more immunoglobulins... | 08/03/2004 |
| 6750028 | Anti-fibrotic agent assay A novel method has been developed for screening anti-scarring and anti-fibrotic agents. This method offers simplicity, it is reproducible and could be adopted to screen large numbers of new potential ant-fibrotic agents. This method has characteristics in common wit... | 06/15/2004 |
| 6719984 | Composition and method for immunomodulation in mammals This invention relates to compositions and processes utilized to modulate the immune system of mammals. More particularly, the present invention relates to the use of low molecular weight substantially immunoglobulin free fractions isolated from mammals to induce a ... | 04/13/2004 |
| 6716434 | Composition and method for immunostimulation in non- mammalian vertebrates This invention relates to compositions utilized to modulate the immune system of non-mammalian vertebrates. More particularly, the present invention relates to the use of low molecular weight substantially immunoglobulin free fractions isolated from mammals to induc... | 04/06/2004 |
| 6649072 | Method for producing autologous platelet-rich plasma A novel method for producing an autologous platelet rich blood composition is described. The resulting blood composition is useful in procedures for enhancing bone fusion, hemostasis, and repairing soft tissue in animals.... | 11/18/2003 |
| 6610496 | Prediction of growth performance and composition in animals, including cattle, from response to growth hormone releasing hormone A method for predicting animal growth performance, which includes administering a suitable amount of growth hormone releasing hormone (GHRH) to an animal, observing levels of growth hormone (GH) subsequent to GHRH administration and; predicting growth and... | 08/26/2003 |
| 6596180 | System and method for the production of autologous platelet gel A centrifuge system for the formation of an autologous platelet gel wherein all of the blood components for the gel are derived from a patient to whom the gel is to be applied. First a platelet rich plasma and a platelet poor plasma are formed by centrifu... | 07/22/2003 |
| 6569427 | Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood The present invention relates to hematopoietic stem and progenitor cells of neonatal or fetal blood that are cryopreserved, and the therapeutic uses of such stem and progenitor cells upon thawing. In particular, the present invention relates to the therap... | 05/27/2003 |
| 6569466 | Conditioning of bioactive glass surfaces in protein containing solutions Conditioning of the surface of silica-based glass or ceramic by differential immersion in a serum protein-containing solution, and the resultant microporous Ca-P surface layer having serum-protein like organic molecules, as defined herein intermingled thr... | 05/27/2003 |
| 6558949 | Media for culturing human cells comprising human serum and method for culturing human cells using the same This invention relates to media for culturing human cells that the proliferation speed of human cells is increased and the cell expression type is stably manifested, and to a method for culturing human cells using the same. This invention is characterized... | 05/06/2003 |
| 6544727 | Methods and devices for the removal of psoralens from blood products Methods and devices for the removal of psoralens and psoralen photoproducts from blood products are described. The methods include contacting a psoralen- and irradiation-treated blood product with a resin capable of adsorbing psoralens and psoralen photop... | 04/08/2003 |
| 6524622 | Method of controlling the working time of a gypsum composition in the bone treatment A method is designed to control the working time, setting time and the semi-solidification time of a gypsum composition in a bone restoration operation. The method involves a preparation of the gypsum composition by mixing an orthopedic gypsum and an aque... | 02/25/2003 |
| 6444228 | Autologous fibrin sealant and method for making the same In general, the present invention relates to a two-phase method for forming an autologous bioadhesive sealant composition or fibrin glue wherein all of the blood components for the bioadhesive sealant are derived from a patient to whom the bioadhesive sea... | 09/03/2002 |
| 6391295 | Artificial bait The present invention relates to an artificial bait for marine animals, comprising cell-free hemolymph of a horseshoe crab. The cell-free hemolymph of the horseshoe crab, which is the byproduct from the manufacture of Limulus Amebocyte Lysate (LAL), is an... | 05/21/2002 |
| 6372262 | Serum-derived factor inducing cell differentiation and medical uses thereof The present invention relates to a biologically active serum-derived composition of matter (SDF), having a low molecular weight, being electrically charged at acidic pH and having absorption at 280 nm. The molecular weight of said SDF was determined by el... | 04/16/2002 |
| 6312733 | Ice crystal growth inhibiting agents from Zoarces viviparus Ice crystal growth inhibiting agents and process for preparing an extract of these agents in which Zoarces viviparus blood is extracted, it is cooled, the supernatant constituting the Zoarces viviparus serum containing the ice crystal growth inhibiting ag... | 11/06/2001 |
| 6303152 | Process for the production of substances that have been bactericidally treated and/or exhibit immune-modulatory activity, and the use thereof A process is disclosed for the production of immune-genetically active suspensions of which the initial substances are fluids or tissues from the human or animal body. Autohemotherapy, immune-stimulatory and/or immune-suppressive effects are employed. The... | 10/16/2001 |
| 6284285 | Tissue repair promoting composition A method for isolating tissue repair promoting substances from human or animal blood, which method comprises collecting the human or animal blood from a single human or animal individual in a first container of a container system comprising at least first... | 09/04/2001 |
| 6224913 | Conditioning of bioactive glass surfaces in protein containing solutions Conditioning of the surface of silica-based glass or ceramic by differential immersion in a serum protein-containing solution, and the resultant microporous Ca--P surface layer having serum-protein like organic molecules, as defined herein intermingled th... | 05/01/2001 |
| 6214357 | Treatment of diabetes The present invention provides methods for using a killed malaria parasite or an extract thereof in the treatment of non-insulin dependent diabetes mellitus (NIDDM).... | 04/10/2001 |
| 6207807 | Method for the separation and purification of immunoglobulins A peptide of formula (I) (H2 N--X1 --Thr--X2 --CO)n --R (I) where X1 and X2, different one another, are an amino acid residue of arginine or tyrosine in configuration L or D, wherein the hydroxy gro... | 03/27/2001 |
| 6143330 | Compositions for inhibiting dental caries and/or middle ear infections and uses thereof Compositions for treating or preventing dental caries and/or middle ear infections. These compositions comprise antibodies to dental caries and/or antibodies to bacteria causing middles ear infections and/or an agent preventing the adhesion, accumulation ... | 11/07/2000 |
| 6084074 | Stabilized aqueous liquid preparations of blood coagulation factor XIII A stabilized aqueous liquid preparation of human blood coagulation factor XIII, prepared by recombinant DNA technology, from the group consisting of galactose, sucrose, sorbitol, glutamate, aspartate and histidine and where little reduction in biological ... | 07/04/2000 |
| 6071919 | Zwitterionic compositions and methods as biological response modifiers A method of treating a disease in a mammal by administering a therapeutic effective amount of an amphoteric zwitterion compound as an active ingredient. A pharmaceutical composition which comprises an amphoteric zwitterionic compound as an active ingredie... | 06/06/2000 |
| 6033688 | Cystic fibrosis therapy The invention provides methods for treating cystic fibrosis and other pathological conditions in mammals using hepatocyte growth factor ("HGF"). The invention also provides articles of manufacture and kits containing HGF.... | 03/07/2000 |
| 6007979 | Method for reduction of the infectiousness of potentially infectious material A method for reduction of the viral infectiousness of potentially infectious material, such as human or animal body fluids or fractions derived therefrom from which biologically active substances can be isolated, wherein the infectiousness is due to non-l... | 12/28/1999 |
| 5981284 | Technique for acceleration of apoptotic cell death A first embodiment of a cell culture system has a cell death accelerator comprising one or more cell death inducing substances, including serum albumin, hemoglobin, glycine and glutamic acid. In a second embodiment a cell death inhibitor comprises one or ... | 11/09/1999 |
| 5968759 | Method for the quantification of activated coagulation factor VII (FVIIa) The invention relates to a method for the quantification of coagulation factor VIIa (F VIIa) in FVIIa- or FVII/FVIIa-containing solutions by means of selective binding to immobilized soluble thromboplastin.... | 10/19/1999 |